Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Regeneron Pharmaceuticals Inc
LSE:0R2M
Regeneron Pharmaceuticals Inc
LSE:0R2M
Price:
761.47
USD
1.37%
Market Cap:
$80B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Regeneron Pharmaceuticals Inc
LSE:0R2M
|
US |
|
Nojima Corp
TSE:7419
|
JP |
|
S
|
Societe Generale SA
SWB:SGE
|
FR |
|
L
|
LVMH Moet Hennessy Louis Vuitton SE
XHAM:MOH
|
FR |
|
T
|
Thales SA
SWB:CSF
|
FR |
|
P
|
Premium Group Co Ltd
OTC:PMMFF
|
JP |
|
C
|
Cemex SAB de CV
SWB:CEXA
|
MX |
|
G
|
General Motors Co
LSE:0R0E
|
US |
|
AIA Group Ltd
HKEX:1299
|
HK |
|
Geberit AG
F:GBRF
|
CH |
|
H
|
Hartford Insurance Group Inc
DUS:HFF
|
US |
|
Honkarakenne Oyj
LSE:0EPR
|
FI |
|
V
|
Vail Resorts Inc
F:VAI
|
US |
|
D
|
Deutsche Bank AG
XMUN:DBK
|
DE |
|
Gold Fields Ltd
F:EDG
|
ZA |
|
I
|
Intel Corp
F:INL
|
US |
|
W
|
Wynn Resorts Ltd
XMUN:WYR
|
US |
|
M
|
Modine Manufacturing Co
SWB:MMF
|
US |
|
Nestle SA
OTC:NSRGF
|
CH |
|
Z
|
Zoetis Inc
XMUN:ZOE
|
US |
|
10X Genomics Inc
LSE:0A88
|
US |
|
Rio Tinto PLC
LSE:RIO
|
UK |
|
I
|
Imperial Brands PLC
DUS:ITB
|
UK |
|
Mitsui & Co Ltd
TSE:8031
|
JP |
Wall St Price Targets
0R2M Price Forecast
Based on 32 analysts
Based on 32 analysts
+14% Upside
from
$761.47
today
Regeneron Pharmaceuticals Inc (0R2M)’s 12-month stock price forecast through September 2027 has a consensus target of $870.65, implying 14% upside. The forecast is based on price targets from 32 Wall Street analysts.
0R2M Analyst Rating
No ratings yet
No ratings yet
Regeneron Pharmaceuticals Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0R2M's stock price target?
Price Target
870.65
USD
870.65
USD
According to Wall Street analysts, the average 1-year price target for 0R2M is 870.65 USD with a low forecast of 669.41 USD and a high forecast of 1 086.05 USD.
What is the Revenue forecast for Regeneron Pharmaceuticals Inc?
Projected CAGR
5%
5%
Over the last 13 years, the compound annual growth rate for Revenue has been 20%. The projected CAGR for the next 8 years is 5%.
What is the Gross Profit forecast for Regeneron Pharmaceuticals Inc?
Projected CAGR
5%
5%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 19%. The projected CAGR for the next 8 years is 5%.
What is the Operating Income forecast for Regeneron Pharmaceuticals Inc?
Projected CAGR
11%
11%
Over the last 13 years, the compound annual growth rate for Operating Income has been 18%. The projected CAGR for the next 8 years is 11%.
What is the Pre-Tax Income forecast for Regeneron Pharmaceuticals Inc?
Projected CAGR
18%
18%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 22%. The projected CAGR for the next 3 years is 18%.
What is the Net Income forecast for Regeneron Pharmaceuticals Inc?
Projected CAGR
8%
8%
Over the last 13 years, the compound annual growth rate for Net Income has been 15%. The projected CAGR for the next 8 years is 8%.